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CASE PRESENTATION
The patient presented herein is a 34-year-old 
woman with nanophthalmos and secondary 
glaucoma. Her mental ability is mildly impaired. 
She has no history of systemic disorders and is 
not receiving any systemic medications except 
acetazolamide 250 mg every 6 hours. She has 
history of bilateral peripheral laser iridectomies, 
phacoemulsification with implantation of a 
posterior chamber intraocular lens (IOL) in 
the right eye, followed by an anterior chamber 
Artisan lens, 5 years before presentation. The 
power of the IOLs was not available. Glaucoma 
had been diagnosed in both eyes since 2 years 
before.
Initial examination upon presentation was 
as follows: best corrected visual acuity was 1/10 
in the right eye with +12, and 6/10 in the left eye 
with +12-1.5×150°. Slit lamp examination of the 
right eye revealed mild conjunctival injection, 
mild corneal haziness and stromal edema, and a 
deep anterior chamber with a centered Artisan 
lens in touch with the corneal endothelium 
peripherally. A peripheral iridectomy was 
present and some posterior synechiae were 
noted between the pupillary margin and the 
posterior chamber IOL. Moderate posterior 
capsule opacity was also evident. In the left 
eye the cornea was clear, the anterior chamber 
was shallow and quiet, there was a peripheral 
iridectomy and the crystalline lens was clear 
(Fig. 1). On gonioscopy, the right eye had 360 
degrees of peripheral anterior synechiae (PAS), 
and the left eye had more than 300 degrees of 
PAS. Intraocular pressure (IOP) was 36 and 
30 mmHg in the right and left eyes respectively 
with Xalatan 0.005% (latanoprost) daily, Cosopt 
(dorzolamide 2% / timolol 0.5%) twice a day, 
brimonidine 0.02% three times a day in both 
eyes, and acetazolamide 250 mg every 6 hours. 
Central corneal thickness (CCT) was 610 and 585 
microns in the right and left eyes respectively. 
Fundus examination revealed a vertical cup/
disc ratio of 0.5 bilaterally, in small crowded 
discs (vertical disc diameters, 1.2 mm) which 
were moderately pale. The fundus examination 
was otherwise unremarkable.
Perimetry was attempted a couple of 
times but was totally unreliable with a clover 
leaf pattern in both eyes. Ocular biometric, 
ultrasonic biomicroscopic (UBM), and 
Pentacam measurements were obtained and 
are summarized in table 1. We were unable to 
capture high quality fundus or optical coherence 
tomography (OCT) images. Anterior visual 
pathway MRI was performed which was normal.
Figure 1. Slit lamp photographs of the right (top) and left 
eyes (bottom) at presentation.Challenging Case; Glaucoma and Nanophthalmos
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What would you recommend regarding 
the management of this patient?
Kouros Nouri-Mahdavi, MD
The patient is a 34-year old female with 
nanophthalmos and mild mental impairment. 
She has no known systemic disorders and 
past ocular history is positive for presumably 
uncomplicated phacoemulsification with 
placement of a posterior chamber IOL in the 
right eye and seemingly secondary implantation 
of an Artisan iris-claw lens and bilateral 
peripheral laser iridectomies. Glaucoma 
developed subsequently with peripheral lens-
cornea touch and posterior synechiae in the 
right eye. The angle is closed for the most 
part in both eyes. IOP is running in the 30s in 
both eyes on maximal treatment, with a fairly 
thick CCT. The patient has small discs with 
significant disc damage and mild pallor in 
both eyes, and a reliable visual field cannot be 
obtained. Based on the biometry, the eyes are 
very small. I assume that the reported anterior 
chamber depth (ACD) represents actual ACD 
and does not include corneal thickness. 
This is indeed a very challenging case. The 
right eye needs to be addressed first because 
of higher IOP and evolving corneal edema. In 
addition to glaucoma management, refractive 
correction is an issue that requires a thorough 
discussion with the patient preoperatively. I 
assume the patient was extremely hyperopic 
after the phacoemulsification and hence, an 
Artisan lens was secondarily placed. At this 
point, the Artisan lens needs to be removed 
before the situation gets more complicated. Since 
the patient is bound to have corneal surgery at 
some point, a glaucoma drainage device is a 
potentially good choice. The eye is, however, 
very small and only a small or pediatric size 
implants (such as a single plate Molteno or 
pediatric Ahmed glaucoma valve) would be 
appropriate, with possibly less efficacy than 
desired. If the superior conjunctiva is untouched, 
my first choice for glaucoma surgery would be 
a trabeculectomy with mitomycin-C (MMC). 
I would remove the Artisan lens and create 
inferior scleral windows on the first surgical 
session before proceeding with trabeculectomy 
in the right eye. Nanophthalmic eyes can get 
into trouble after any type of drainage surgery 
because of poor drainage of the vortex veins 
and very thick sclera. Obviously, the patient 
would end up extremely hyperopic again. 
Unfortunately, there are no good options 
available for her at this point. A piggyback 
lens would be asking for more trouble since 
the anterior chamber cannot accommodate any 
further volume. I would also be reluctant to 
consider IOL exchange. We may have to settle 
for contact lenses postoperatively although with 
her steep corneas this may also be problematic. 
I would obtain a refractive surgery consultation 
before any intervention to see if any rarely used 
corneal surgical option such as epikeratophakia 
would be appropriate in this particular case. 
If the trabeculectomy fails in the right eye, 
one could always resort to a tube. For the 
left eye, given the history of uncomplicated 
phacoemulsification in the right eye, I would 
suggest removal of the crystalline lens with 
inferior scleral windows on the first surgical 
session with subsequent trabeculectomy after 
2 to 3 months. It is now possible to find IOLs 
in very high powers (> 40 D), which may be 
appropriate for the left eye. Alternatively, a 
customized IOL with appropriate power could 
be ordered while she is having surgery in her 
right eye. Obviously, IOL power would depend 
on availability and final correction in the right 
eye. One possibility would be to relinquish 
improving refractive correction in the right eye 
and concentrate on getting the best possible 
correction on the left.
Right eye Left eye
Axial length 15.3 mm 15.7 mm
Anterior chamber depth 2.57 mm 1.57 mm
IOL power calculation by 
Hoffer Q Formula
57 diopters 55 diopters
Sulcus to sulcus diameter by 
UBM
9 mm 9 mm
Mean keratometry 50.9 diopters 50.2 diopters
Anterior chamber volume 87 mm3 62 mm3
Anterior chamber angle 45° 19.2°
Table 1. Major ocular biometric, ultrasonic biomicro-
scopic and Pentacam data
IOL, intraocular lens; UBM, ultrasonic biomicroscopyChallenging Case; Glaucoma and Nanophthalmos
210 JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2011; Vol. 6, No. 3
One final note is that given the high 
risk of complications following any type of 
intraocular surgery, all the risks and benefits 
of intervention should be discussed with the 
patient before proceeding.
Naveed Nilforushan, MD
Management of eyes with nanophthalmos is 
always a dilemma for the ophthalmologist, 
especially if the condition is associated with 
glaucoma. The main concern with any type of 
penetrating surgery in these patients is the high 
risk of sight-threatening intra- and postoperative 
complications. These include but are not limited 
to malignant glaucoma, choroidal and retinal 
detachment, suprachoroidal hemorrhage, flat 
anterior chamber and corneal decompensation. 
A detailed history of previous surgery on the 
fellow eye and its complications could help 
make a better decision for the other eye. In 
nanophthalmic eyes, a diagnosis of glaucoma 
and its progression is often complicated. The 
disc is small, so even slight cupping could be a 
sign of glaucoma. Visual field testing in patients 
with high plus lenses and low vision (due to 
amblyopia or posterior pole folds from uveal 
effusion) can be misleading and inaccurate. In this 
young patient with uncontrolled angle closure 
glaucoma on maximum medical therapy, surgery 
would be the only choice. In general, before 
any intraocular procedure in nanophthalmic 
eyes, UBM and posterior segment B scan 
should be performed. These tests can provide 
valuable information regarding the presence 
of supraciliary and choroidal effusion, and 
choroidal and scleral thickness. In this particular 
case and for the right eye with corneal edema, an 
Artisan IOL and high IOP my suggestions are:
1.  Surgery under general anesthesia with 20% 
mannitol serum injection before starting 
the procedure.
2.  If there is choroidal thickening or any 
suspicion of uveal effusion on B-scan or 
fundus examination, I would first perform 
an anterior sclerotomy in both inferior 
quadrants.
3.  The next step would be anterior chamber 
IOL removal via a corneolimbal incision. 
Injection of cohesive viscoelastics, such 
as Healon GV and Healon 5, before IOL 
removal maintains ACD and reduces the 
risk of endothelial damage, uveal effusion 
and aqueous misdirection.
4.  If everything goes well and the conjunctiva 
is sufficient with only slight scarring 
from previous surgery, MMC augmented 
trabeculectomy with tight scleral flap 
sutures can be performed. Otherwise, a 
small size Ahmed valve (model FP8 or 
S3) can be implanted. If both of the above-
mentioned procedures are not feasible, 
limited endoscopic cyclophotocoagulation 
(not more than 180°), using low laser power 
and long duration would be my next option.
5.  Atropinizing the eye and subconjunctival 
injection of corticosteroids should be 
performed at the end of surgery.
6.  Systemic corticosteroids should be 
prescribed a few days before and after 
surgery. This may decrease the risk of uveal 
effusion or help resolve subtle undetectable 
existing effusion.
In the left eye, for better control of 
IOP and prevention of progressive angle 
closure, lens aspiration and implantation of a 
foldable posterior chamber IOL together with 
viscogoniosynechialysis is recommended. Based 
on preoperative refraction and IOL calculation, 
it seems that the lens is more or less spherical. 
Thus, removing the lens will probably deepen 
the anterior chamber angle significantly. I prefer 
to implant a single lens in the bag (with highest 
available power, +40) and have some residual 
refractive error rather than use piggyback IOLs 
with possible complications of interlenticular 
opacity, decentration, pigment dispersion and 
hyperopic shift. For the left eye, the same 
considerations mentioned for the right eye 
should be taken into account. In addition, we 
have to keep in mind that any manipulation 
may be associated with disastrous intra- and 
postoperative complications.
Mohammad-Reza Razeghinejad, MD
The presented patient is a case of nanophthalmos 
with the following issues:Challenging Case; Glaucoma and Nanophthalmos
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1.  Uncontrolled IOP.
2.  Progressive corneal endothelial damage in 
the right eye due to contact with the IOL.
3.  Refractive error.
4.  Progressive PAS formation in the left eye.
These are discussed individually below:
1. Uncontrolled IOP: The patient is receiving 
maximum medical therapy and still has 
uncontrolled IOP. The Goldmann tonometer is 
assumed to measure IOP accurately when CCT 
is 520 microns and many correction formulas 
have been introduced for thicker and thinner 
corneas. Although almost all reports agree 
that CCT affects IOP measurement, there is 
no consensus regarding a specific formula for 
IOP correction in routine clinical practice. In 
addition to CCT, corneal biomechanics also 
affect measured IOP.
The level of IOP in this particular patient 
is high and surgical intervention is necessary, 
despite the fact that surgery in nanophthalmic 
eyes has an extremely high complication rate 
with potentially disastrous results. Singh et al 
reported that 60% of 15 nanophthalmic patients 
undergoing filtration surgery for glaucoma 
failed to achieve control and 86.6% sustained 
visual loss.
Regarding the high rate of choroidal 
effusion or hemorrhage and exudative retinal 
detachment in nanophthalmic eyes following 
any kind of surgery including laser iridotomy, it 
is necessary to make prophylactic sclerostomies 
in both inferior quadrants before creating any 
opening into the eye. Trabeculectomy with 
antifibrotics and tight releasable sutures can 
be employed, but this may still be associated 
with early postoperative hypotony resulting in 
choroidal effusion or hemorrhage. I would prefer 
a Molteno tube implantation; tube ligature with 
Vicryl sutures will prevent early postoperative 
hypotony. After 4 to 6 weeks, when a fibrous 
capsule has formed around the shunt plate, 
the Vicryl suture dissolves and IOP reduction 
occurs gradually. Considering the short axial 
length, if the available shunt is Ahmed, I would 
rather trim the posterior third of the plate (FP7) 
to prevent possible optic nerve compression. 
Based on the “Trabeculectomy versus Tube” 
trial, IOPs in the low teens are achievable with 
shunts, as attained in 62% of patients in the 
tube group at 3 years.
2. Progressive corneal endothelial damage: 
There is no doubt that the Artisan lens should 
be explanted because of contact with the 
cornea and progressive endothelial damage. 
Before performing any type of intraocular 
surgery I would prefer to obtain a specular 
microscopy and discuss the possibility of 
corneal decompensation with the patient if the 
cell count is low.
3. Refractive error: To correct the refractive 
error in the right eye, a three-piece IOL can 
be implanted in the sulcus after removing the 
Artisan lens. Power calculation for piggyback 
IOLs is independent of axial length but relies 
on careful manifest refraction. For eyes with 
hyperopic errors up to 7 D, the spherical 
equivalent (SE) can be multiplied by 1.5. For 
myopic errors up to 7 D, SE can be adjusted by 
a factor of 1.3. In eyes with a power surprise 
outside the ±7 D range, or if increased accuracy 
is sought, the Holladay R formula (refractive 
vergence formula) can be used which is 
available at: http://doctor-hill.com/physicians/
download.htm#four.
Although there is a space between the 
two implanted lenses (Artisan and posterior 
chamber IOL) which may affect the refractive 
error and consequently, measured piggyback 
IOL power, the two mentioned formulas seem to 
be the only available methods for determining 
piggyback IOL power in this patient. In order 
to calculate piggyback IOL power in the right 
eye using the refractive vergence formula, we 
need to know K1, K2, effective lens position 
(calculated by subtracting 0.65 mm from the IOL 
manufacturer’s bag ACD), and vertex distance. 
With the available data, I cannot calculate the 
power of the piggyback IOL. The left eye can 
receive in the bag and piggyback IOLs after 
lens extraction.
4. Progressive PAS formation in the left eye: 
Patients with nanophthalmic eyes have normal 
or thick lens and high lens-to-eye volume ratio. 
This ratio, which is about 4% in normal eyes, 
is increased up to 10 to 30% in nanophthalmos. 
Aging is associated with an increase in lens 
thickness which makes the iridocorneal angle Challenging Case; Glaucoma and Nanophthalmos
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narrower and PAS more extensive. To prevent 
PAS formation at the open portion of the angle 
and release existing PAS, phacoemulsification 
and IOL implantation combined with 
viscogoniosynechialysis seems to be an effective 
procedure. If this procedure cannot control 
the IOP, filtering surgery is necessary but 
considering probable complications, I would 
prefer a shunt procedure. 
All in all, my surgical plan for this patient 
would include Artisan lens explantation, 
piggyback IOL implantation, shunt surgery, 
and prophylactic sclerostomies for the 
right eye; and phacoemulsification, IOL 
implantation, viscogoniosynechialysis, and 
prophylactic sclerostomies in the left eye. If 
IOP is still not controlled in the left eye, my 
next recommendation would be shunt surgery.
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Heydar Amini, MD
This is a case of nanophthalmos in a young 
woman complicated by secondary glaucoma; 
however, other diagnoses such as simple 
and posterior microphthalmos may be 
considered. Nanophthalmic patients have small 
corneal diameter, while those with posterior 
microphthalmos have normal-sized corneas. In 
addition, other ocular anomalies, especially in 
the posterior segment are typical of complex 
microphthalmos. The patient has slight mental 
disability, which is the case in one-fifth of 
nanophthalmic patients.
The Artisan IOL is in touch with the 
peripheral corneal endothelium in the right 
eye and this could result in progressive corneal 
decompensation and synechiae formation. 
The patient has corneal edema which denotes 
compromised endothelial function. Knowledge 
of endothelial cell counts would aid in decision 
making. I am dubious about the initial decision 
for implanting an Artisan IOL, since this 
procedure is contraindicated in eyes with 
shallow anterior chamber (ACD less than 
2.7 mm, measured from the endothelium). ACD 
in the right eye was reported to be 2.57 mm. 
However, if the measurement is performed by 
ultrasonic methods, it is representative of ACD 
measured from the epithelium. Considering 
a CCT of 610 microns, the endothelial ACD 
should be about 1.96 mm, which is far less 
than the recommended safe limit. With these 
considerations, I believe that removal of the 
Artisan IOL is necessary. I need an endothelial 
cell count to decide on the next surgical step. 
There are two major clinical scenarios in this 
situation. If there is sufficient endothelial reserve 
and the corneal edema is due to a “stressed” 
endothelium, I would proceed with implantation 
of a piggyback IOL. The posterior synechiae 
should be released during this procedure. 
In the more probable clinical situation of 
decreased endothelial reserve, I would remove 
the Artisan IOL and postpone additional 
refractive correction. There is evidence that in 
this situation, endothelial cells may repopulate 
or at least undergo redistribution after removal 
of the offending IOL. 
The eye is not quiet and there is a high 
rate of failure in such cases. Before surgery, I 
would prescribe a short course of topical steroids 
and tear substitutes to decrease conjunctival 
hyperemia. I would perform goniosynechialysis 
during Artisan removal; this can decrease 
intraocular pressure in some patients. If IOP 
does not fall to the desired level, my first Challenging Case; Glaucoma and Nanophthalmos
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choice for glaucoma management in the right 
eye would be an aqueous drainage device 
(ADD) and I would choose a small Ahmed 
glaucoma valve (FP8 Ahmed glaucoma valve; 
New World Medical Inc., Rancho Cucamonga, 
CA, USA). To further decrease the risk of 
sudden ocular decompression I would fill the 
anterior chamber with viscoelastic agents and 
ligate the tube. If the patient has sufficient 
endothelial count, I would place the tube into 
the anterior chamber and reserve the ciliary 
sulcus for piggyback IOL. On the other hand, 
if endothelial count is critically low, I would 
insert the tube into the ciliary sulcus to prevent 
further endothelial damage. By this means, 
prophylactic sclerotomies are not obligatory; 
however, in high-risk patients it would be 
preferable to have anterior sclerotomies in the 
inferior quadrants.
Other modalities such as endoscopic 
cyclophotocoagulation (ECP) could also be used; 
however, the surgeon should be cautious about 
possible complications. In the past decade, I have 
attempted trans-scleral cyclophotocoagulation 
in a number of nanophthalmic patients with 
advanced glaucoma. Unfortunately, there was 
an unacceptably high rate of complications in 
these patients, resulting in phthisis bulbi. 
In the left eye, after ruling out ciliary 
effusion and the possibility of malignant 
glaucoma following laser iridotomy, I would 
proceed to argon laser peripheral iridoplasty 
(ALPI). This could alleviate some of the 
appositional angle closure and decrease IOP 
to a safe level. If IOP remains uncontrollable, 
my next step would be phacoemulsification 
and viscogoniosynechialysis. One could create 
prophylactic sclerotomies to avoid intraoperative 
complications. In refractory cases, one could 
proceed to trabeculectomy with MMC and 
inferior sclerotomies, or alternatively, ADD, 
as described for the right eye.
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Shamira A Perera, MBBS, BSc, FRCOphth
In summary, this is a 34-year-old nanophthalmic 
woman with extensive, bilateral synechial angle 
closure. She has uncontrolled IOP in both eyes, 
despite maximal medical therapy. Additionally, 
she has early corneal decompensation in her 
right eye secondary to an iris clip lens.
The diagnosis and management of glaucoma 
in this case is challenging. The thick CCT 
overestimates Goldmann IOP, the small diameter 
disc may belie marked retinal nerve fiber layer Challenging Case; Glaucoma and Nanophthalmos
214 JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2011; Vol. 6, No. 3
(RNFL) loss, and the inability to perform visual 
field testing robs the clinician of a functional 
test for monitoring progression. In such cases 
a spectral domain OCT may detect subtle 
wedge-shaped RNFL defects, Heidelberg retinal 
tomography may monitor deterioration of disc 
parameters, and stereophotographs could offer 
reliable, contemporaneous documentation of 
disc morphology.
Nanophthalmic eyes have significant 
choroidal congestion secondary to impaired 
vortex venous drainage through the 
characteristically thickened sclera. They also 
have a high lens/eye volume ratio. Because 
of potentially blinding complications such as 
uveal effusion and serous retinal detachment 
associated with surgical intervention in these 
eyes, it is prudent to counsel the patient 
thoroughly. 
In preparation, a preoperative UBM can seek 
the presence of subclinical choroidal effusion, 
primarily to predict the risk of effusion-related 
complications, but also for any superimposed 
lens subluxation.
To control IOP in the left eye, my approach 
would be a phacoemulsification with IOL 
implantation and trabeculectomy with MMC 
(0.2 mg/ml for 2 minutes) under peribulbar 
anesthesia. Preoperative intravenous mannitol 
infusion and prophylactic partial thickness 
sclerectomies and sclerostomies placed inferiorly 
would play an important role in ensuring safe 
surgery and a desirable outcome. Having said 
this, previous cataract surgery in the right eye 
had been uneventful and there was no note of 
uveal effusion in the history. Preplaced sutures, 
utilizing an anterior chamber maintainer and use 
of viscoelastics in the eye at the end of surgery 
could be an alternative approach to sclerotomy/
sclerectomy. Tight flap sutures would ensure 
slow titration of IOP to an adequate level in 
the postoperative phase.
Some may argue that lens extraction is 
unnecessary considering the satisfactory visual 
acuity of 6/10. However, nanophthalmic eyes 
are predisposed to potential complications such 
as malignant glaucoma and suprachoroidal 
hemorrhage. These complications are more 
amenable to procedures such as hyaloidotomy 
if the eye is pseudophakic. Furthermore, this 
offers a refractive solution to the +12 hyperopia. 
Finally, cyclophotocoagulation is another option 
if the patient considers it too risky to perform 
surgery on their only eye.
My preferred management for the right eye 
would be to explant the iris clip lens very soon. 
This would be combined with a trabeculectomy 
augmented with MMC, utilizing the same 
precautions discussed earlier. An endothelial cell 
count would be useful in planning any further 
visual rehabilitation, either by a piggyback lens 
in the sulcus or a subsequent corneal graft if 
there is significant corneal decompensation.
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